This paper discusses ovarian cancer beginning with an interview of a patient named Melinda. This paper attempts to review the current status of the management of women with early-stage ovarian cancer. As the paper makes clear, despite the efforts of numerous cancer research groups around the world, an optimal treatment strategy for early-stage ovarian cancer has yet to be defined.